The determination of causality of drug induced liver injury in patients with COVID-19 clinical syndrome.

The determination of causality of drug induced liver injury in patients with COVID-19 clinical syndrome.

<h4>Background</h4>Drug induced liver injury (DILI) is a rising morbidity amongst patients with COVID-19 clinical syndrome. The updated RUCAM causality assessment scale is validated for use in the general population, but its utility for causality determination in cohorts of patients with...

Full description

Bibliographic Details
Main Authors: Lina Mohammad Naseralallah, Bodoor Abdallah Aboujabal, Nejat Mohamed Geryo, Aisha Al Boinin, Fatima Al Hattab, Raza Akbar, Waseem Umer, Layla Abdul Jabbar, Mohammed I Danjuma
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0268705&type=printable

Internet

https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0268705&type=printable

Similar Items